HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythroderma due to ribostamycin.

Abstract
A 48-year-old man became erythrodermatous after intramuscular administration of ribostamycin, an aminoglycoside antibiotic in the same family as neomycin. Patch tests were positive to ribostamycin and neomycin, as well as to mercurials. There was no mercurial preservative in the injection solution. A lymphocyte transformation test was positive for ribostamycin and tobramycin, but not for gentamycin. Diagnostic and structure-activity relationship aspects of the case are discussed.
AuthorsL L Puig, M Abadias, A Alomar
JournalContact dermatitis (Contact Dermatitis) Vol. 21 Issue 2 Pg. 79-82 (Aug 1989) ISSN: 0105-1873 [Print] England
PMID2530055 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Ribostamycin
Topics
  • Anti-Bacterial Agents (adverse effects)
  • Dermatitis, Exfoliative (chemically induced)
  • Drug Eruptions (diagnosis, drug therapy, etiology)
  • Humans
  • Male
  • Middle Aged
  • Patch Tests
  • Ribostamycin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: